Trek Therapeutics

Jerry is CEO of Celgene Global Health and Chief Medical Officer of Celgene Corporation. Prior to that he was Celgene’s Senior Vice President of Clinical Research and Medical Affairs and has been at Celgene since February 1997. He attended Brown University for an AB, MS, followed by Yale University for a MPhil, MD, PhD in molecular biophysics and biochemistry (immunochemistry). Prior to working at Celgene, Dr. Zeldis worked at Sandoz Research Institute and Janssen Research Institute in both clinical research and medical development. He currently on the board of the Alliqua, Semorex Corporation, PTC Corporation, Soligenix, and BionorPharma. Of the 122 peer reviewed articles he has published, 35 are related to viral hepatitis. Dr. Zeldis is named an inventor on over 30 US patents.